Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Contact
Search
×
Cancer Tissue Gallery HLA-DRa
Path
Created with Sketch.
Go to HLA-DRa Normal Tissue Gallery
Go back to Product Page
Adrenal gland- Adrenocortical adenoma showing moderate to strong focal HLA-DRa immunostaining in tumor cells.
Adrenal gland- Adrenocortical adenoma showing moderate to strong focal HLA-DRa immunostaining in tumor cells.
Colon- Colorectal adenocarcinoma showing diffuse strong HLA-DRa positivity of tumor cells and tumor associated inflammatory cells.
Colon- Colorectal adenocarcinoma showing diffuse strong HLA-DRa positivity of tumor cells and tumor associated inflammatory cells.
Colon- HLA-DR negative colorectal adenocarcinoma showing strong HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Colon- HLA-DR negative colorectal adenocarcinoma showing strong HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Esophagus- HLA-DR negative esophageal squamous cell carcinoma with strong HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Esophagus- HLA-DR negative esophageal squamous cell carcinoma with strong HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Kidney- Clear cell renal cell carcinoma showing strong HLA-DRa immunostaining in tumor cells.
Kidney- Clear cell renal cell carcinoma showing strong HLA-DRa immunostaining in tumor cells.
Kidney- HLA-DR negative clear cell renal cell carcinoma showing strong HLA-DRa immunostaining in small blood vessels.
Kidney- HLA-DR negative clear cell renal cell carcinoma showing strong HLA-DRa immunostaining in small blood vessels.
Kidney- HLA-DR negative oncocytoma exhibiting strong HLA-DRa immunostaining in capillaries.
Kidney- HLA-DR negative oncocytoma exhibiting strong HLA-DRa immunostaining in capillaries.
Kidney- HLA-DR negative papillary renal cell carcinoma showing strong HLA-DRa immunostaining in small blood vessels and macrophages.
Kidney- HLA-DR negative papillary renal cell carcinoma showing strong HLA-DRa immunostaining in small blood vessels and macrophages.
Larynx- HLA-DR negative squamous cell carcinoma showing HLA-DRa immunostaining of capillaries and tumor associated inflammatory cells.
Larynx- HLA-DR negative squamous cell carcinoma showing HLA-DRa immunostaining of capillaries and tumor associated inflammatory cells.
Liver- Hepatocellular carcinoma with strong HLA-DRa positivity of tumor cells.
Liver- Hepatocellular carcinoma with strong HLA-DRa positivity of tumor cells.
Lung- Adenocarcinoma showing strong HLA-DRa immunostaining in tumor cells.
Lung- Adenocarcinoma showing strong HLA-DRa immunostaining in tumor cells.
Lung- HLA-DR negative adenocarcinoma containing numerous HLA-DRa positive macrophages and blood vessels.
Lung- HLA-DR negative adenocarcinoma containing numerous HLA-DRa positive macrophages and blood vessels.
Lymph node- Follicular B-cell lymphoma showing strong HLA-DRa immunostaining in tumor cells.
Lymph node- Follicular B-cell lymphoma showing strong HLA-DRa immunostaining in tumor cells.
Lymph node- Hodgkin‘s lymphoma showing strong HLA-DRa immunostaining in tumor cells.
Lymph node- Hodgkin‘s lymphoma showing strong HLA-DRa immunostaining in tumor cells.
Lymph node- Hodgkin‘s lymphoma with strong HLA-DRa immunostaining of tumor cells.
Lymph node- Hodgkin‘s lymphoma with strong HLA-DRa immunostaining of tumor cells.
Lymph node- Strong HLA-DRa immunostaining in all tumor cells of a diffuse large B-cell lymphoma.
Lymph node- Strong HLA-DRa immunostaining in all tumor cells of a diffuse large B-cell lymphoma.
Pancreas- Ductal adenocarcinoma showing diffuse strong HLA-DRa positivity of tumor cells, tumor associated inflammatory cells and capillaries.
Pancreas- Ductal adenocarcinoma showing diffuse strong HLA-DRa positivity of tumor cells, tumor associated inflammatory cells and capillaries.
Pancreas- HLA-DR negative adenocarcinoma of the ampulla Vaterii showing HLA-DRa positivity of tumor associated capillaries and inflammatory cells.
Pancreas- HLA-DR negative adenocarcinoma of the ampulla Vaterii showing HLA-DRa positivity of tumor associated capillaries and inflammatory cells.
Pancreas- HLA-DR negative ductal adenocarcinoma showing strong HLA-DRa positivity of tumor associated inflammatory cells.
Pancreas- HLA-DR negative ductal adenocarcinoma showing strong HLA-DRa positivity of tumor associated inflammatory cells.
Pancreas- HLA-DR negative neuroendocrine tumor showing HLA-DRa immunostaining of capillaries and inflammatory cells.
Pancreas- HLA-DR negative neuroendocrine tumor showing HLA-DRa immunostaining of capillaries and inflammatory cells.
Penis- HLA-DR negative squamous cell carcinoma containing HLA-DRa positive macrophages.
Penis- HLA-DR negative squamous cell carcinoma containing HLA-DRa positive macrophages.
Prostate- Adenocarcinoma (Gleason 3+3=6) with HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Prostate- Adenocarcinoma (Gleason 3+3=6) with HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Stomach- Gastric adenocarcinoma showing diffuse strong HLA-DRa positivity of tumor cells.
Stomach- Gastric adenocarcinoma showing diffuse strong HLA-DRa positivity of tumor cells.
Stomach- Gastric adenocarcinoma showing moderate to strong focal HLA-DRa immunostaining in tumor cells.
Stomach- Gastric adenocarcinoma showing moderate to strong focal HLA-DRa immunostaining in tumor cells.
Stomach- Gastrointestinal stromal tumor (GIST) showing strong HLA-DRa immunostaining of tumor cells.
Stomach- Gastrointestinal stromal tumor (GIST) showing strong HLA-DRa immunostaining of tumor cells.
Stomach- HLA-DR negative gastric adenocarcinoma with HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Stomach- HLA-DR negative gastric adenocarcinoma with HLA-DRa positivity of capillaries and tumor associated inflammatory cells.
Stomach- HLA-DRa negative gastrointestinal stromal tumor (GIST) showing HLA-DR immunostaining of tumor associated capillaries.
Stomach- HLA-DRa negative gastrointestinal stromal tumor (GIST) showing HLA-DR immunostaining of tumor associated capillaries.
Testis- HLA-DR negative seminoma with strong HLA-DRa immunostaining in capillaries and inflammatory cells.
Testis- HLA-DR negative seminoma with strong HLA-DRa immunostaining in capillaries and inflammatory cells.
Thyroid- HLA-DR negative papillary carcinoma showing HLA-DRa immunostaining of capillaries and inflammatory cells.
Thyroid- HLA-DR negative papillary carcinoma showing HLA-DRa immunostaining of capillaries and inflammatory cells.
Urinary bladder- Muscle-invasive urothelial carcinoma showing strong HLA-DRa immunostaining in tumor cells.
Urinary bladder- Muscle-invasive urothelial carcinoma showing strong HLA-DRa immunostaining in tumor cells.
Vulva- Squamous cell carcinoma showing strong HLA-DRa immunostaining in tumor cells.
Vulva- Squamous cell carcinoma showing strong HLA-DRa immunostaining in tumor cells.